RhumbLine Advisers’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-46,921
| Closed | -$66K | – | 3313 |
|
|
2022
Q1 | $66K | Sell |
46,921
-4,810
| -9% | -$10.3K | ﹤0.01% | 2951 |
|
|
2021
Q4 | $141K | Sell |
51,731
-48,783
| -49% | -$180K | ﹤0.01% | 2898 |
|
|
2021
Q3 | $478K | Sell |
100,514
-13,231
| -12% | -$96.6K | ﹤0.01% | 2569 |
|
|
2021
Q2 | $918K | Sell |
113,745
-6,435
| -5% | -$53.6K | ﹤0.01% | 2280 |
|
|
2021
Q1 | $964K | Buy |
120,180
+548
| +0.5% | +$5.11K | ﹤0.01% | 2205 |
|
|
2020
Q4 | $1.07M | Buy |
119,632
+13,690
| +13% | +$114K | ﹤0.01% | 2100 |
|
|
2020
Q3 | $797K | Sell |
105,942
-6,140
| -5% | -$42.6K | ﹤0.01% | 2079 |
|
|
2020
Q2 | $714K | Sell |
112,082
-9,067
| -7% | -$60.7K | ﹤0.01% | 2188 |
|
|
2020
Q1 | $900K | Buy |
121,149
+6,967
| +6% | +$54K | ﹤0.01% | 1925 |
|
|
2019
Q4 | $1.03M | Buy |
114,182
+4,403
| +4% | +$37K | ﹤0.01% | 2069 |
|
|
2019
Q3 | $823K | Buy |
109,779
+6,198
| +6% | +$34.8K | ﹤0.01% | 2130 |
|
|
2019
Q2 | $538K | Buy |
103,581
+4,532
| +5% | +$29.5K | ﹤0.01% | 2332 |
|
|
2019
Q1 | $829K | Buy |
99,049
+624
| +0.6% | +$4.49K | ﹤0.01% | 2121 |
|
|
2018
Q4 | $423K | Buy |
98,425
+15,758
| +19% | +$139K | ﹤0.01% | 2376 |
|
|
2018
Q3 | $1.2M | Sell |
82,667
-53
| -0.1% | -$878 | ﹤0.01% | 1920 |
|
|
2018
Q2 | $1.54M | Buy |
82,720
+2,602
| +3% | +$47.1K | ﹤0.01% | 1814 |
|
|
2018
Q1 | $1.39M | Buy |
80,118
+2,188
| +3% | +$38.6K | ﹤0.01% | 1793 |
|
|
2017
Q4 | $1.31M | Buy |
77,930
+10,666
| +16% | +$174K | ﹤0.01% | 1827 |
|
|
2017
Q3 | $1.06M | Buy |
67,264
+1,934
| +3% | +$27.6K | ﹤0.01% | 1938 |
|
|
2017
Q2 | $862K | Buy |
65,330
+442
| +0.7% | +$5.81K | ﹤0.01% | 2021 |
|
|
2017
Q1 | $772K | Buy |
64,888
+17,364
| +37% | +$208K | ﹤0.01% | 2043 |
|
|
2016
Q4 | $620K | Sell |
47,524
-5,108
| -10% | -$58.8K | ﹤0.01% | 2116 |
|
|
2016
Q3 | $588K | Buy |
52,632
+1,910
| +4% | +$23K | ﹤0.01% | 2108 |
|
|
2016
Q2 | $615K | Sell |
50,722
-6,017
| -11% | -$70.9K | ﹤0.01% | 2076 |
|
|
2016
Q1 | $747K | Buy |
56,739
+4,665
| +9% | +$66.2K | ﹤0.01% | 1976 |
|
|
2015
Q4 | $906K | Buy |
52,074
+1,960
| +4% | +$35.4K | ﹤0.01% | 1875 |
|
|
2015
Q3 | $725K | Buy |
50,114
+2,334
| +5% | +$40.8K | ﹤0.01% | 1982 |
|
|
2015
Q2 | $1.03M | Sell |
47,780
-4,205
| -8% | -$89.1K | ﹤0.01% | 1849 |
|
|
2015
Q1 | $1.01M | Buy |
51,985
+1,800
| +4% | +$31.2K | ﹤0.01% | 1853 |
|
|
2014
Q4 | $841K | Buy |
50,185
+2,235
| +5% | +$33.9K | ﹤0.01% | 1930 |
|
|
2014
Q3 | $566K | Sell |
47,950
-810
| -2% | -$12.3K | ﹤0.01% | 2128 |
|
|
2014
Q2 | $896K | Sell |
48,760
-1,693
| -3% | -$28.7K | ﹤0.01% | 1903 |
|
|
2014
Q1 | $962K | Sell |
50,453
-1,460
| -3% | -$30K | ﹤0.01% | 1828 |
|
|
2013
Q4 | $1.21M | Sell |
51,913
-1,660
| -3% | -$34.4K | ﹤0.01% | 1680 |
|
|
2013
Q3 | $925K | Sell |
53,573
-645
| -1% | -$10.2K | ﹤0.01% | 1828 |
|
|
2013
Q2 | $779K | Buy |
+54,218
| New | +$751K | ﹤0.01% | 1931 |
|
Other funds holding IVC
RCM
RhumbLine Advisers's IVC Position: Q2 2022 in Review
RhumbLine Advisers sold out of Invacare Corporation (IVC) in Q2 2022, closing a stake of 46,921 shares — an estimated $66K sold.
RhumbLine Advisers first reported a position in IVC in Q2 2013 and held it in 36 quarters. The position peaked at $1.54M in Q2 2018. 83 funds tracked by Wall St. Rank hold IVC as of Q2 2022.
- RhumbLine Advisers reported no remaining Invacare Corporation position as of Q2 2022 after selling out during the quarter.
- RhumbLine Advisers sold 46,921 Invacare Corporation shares in Q2 2022, an estimated $66K.
- RhumbLine Advisers first reported a position in Invacare Corporation in Q2 2013 and held it in 36 quarters.
- RhumbLine Advisers's Invacare Corporation position peaked at $1.54M in Q2 2018.
- 83 funds tracked by Wall St. Rank held Invacare Corporation as of Q2 2022.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.